
    
      Additional Study Purpose Details: Investigation of the pharmacokinetics, safety, and
      tolerability of a single dose of PD 0332334 in patients with impaired renal function.

      On February 23rd 2009, a decision to terminate further development for PD 0332334 was
      communicated to investigators in this study. The decision to terminate this study was not
      based on any safety concerns.
    
  